A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
A resource hub for all things Premier.
Find what you’re looking for, fast! Select a category or topic to get to what matters to you most.
The future of life sciences is hurtling towards a digital revolution with emphasis on immediacy for the pharmaceutical, biopharmaceutical, and medical device technology value chain.
The power of RWD and RWE continues to play a key role in helping increase research efficiency and accelerate the introduction of new treatments.
Premier data highlights three key factors that contributed to recent drug shortages.
Premier weighs in on the framework for the Digital Health Technologies in Drug and Biological Product Development.
More and more researchers are turning to actionable insights derived from the PINC AI™ Healthcare Database to further knowledge about cancer.
bioMérieux and PINC AI™ Applied Sciences collaborate to understand the epidemiology, HRU and costs related to AGE in adult patients.
Remitra® can help minimize burnout and turnover associated with overwhelming manual workloads and give staff time for more challenging work that drives healthcare forward.
Partnering with PINC AI™ Stanson’s clinical decision support (CDS) technology platform empowered a large health system in Missouri to significantly improve HCC coding accuracy.
Premier’s Chief Pharmacy Officer Jessica Daley joins a panel of experts to discuss strategies to manage and mitigate drug shortages.
In this Executive Roundtable sponsored by Remitra®, participants discussed ways to relieve labor cost increases, inflation, declining Medicare reimbursements and clawbacks.
The Cone Health team implemented the PINC AI™ Quality Enterprise to help with early sepsis recognition and to reduce mortality and cost.
Premier submitted comments to the Drug Enforcement Agency on the prescribing of controlled substances via telehealth upon the end of the public health emergency.